Together, these findings indicate that REDD1 may act to impair insulin action under conditions where its expression and/or activity becomes either aberrantly elevated, for example in obesity and/or diabetes, or when it is substantially suppressed (i.e., through genetic inhibition). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.